General Information of This Antibody
Antibody ID
ANTI0JGFSG
Antibody Name
54E
Organization
ICONIC THERAPEUTICS LLC
Synonyms
54E
   Click to Show/Hide
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized lgG
Antigen Name
Tissue factor (F3)
 Antigen Info 
Click to Show/Hide the Sequence Information of This Antibody
Heavy Chain Varible Domain
QVQLVQSGAEVKKPGASVKVSCKASGYTFANYYMHWVRQAPGQGLEWMGIINPSGGITVY
AQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGGSKVAALAFDIWGQGTMVTVS
S
    Click to Show/Hide
Heavy Chain CDR 1
GYTFANYYMH
    Click to Show/Hide
Heavy Chain CDR 2
IINPSGGITVYAQKFQG
    Click to Show/Hide
Heavy Chain CDR 3
GGSKVAALAFDI
    Click to Show/Hide
Light Chain Varible Domain
DIQMTQSPSSLSASVGDRVTITCQASQDISNSLNWYQQKPGKAPKLLIYDASNLETGVPS
RFSGSRSGTDFTFTISSLQPEDIATYYCQQYNFHPLTFGGGTKVEIK
    Click to Show/Hide
Light Chain CDR 1
QASQDISNSLN
    Click to Show/Hide
Light Chain CDR 2
DASNLET
    Click to Show/Hide
Light Chain CDR 3
QQYNFHPLT
    Click to Show/Hide
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
EP4495597A2 54E-MMAE [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.11 nM
Positive TF expression (TF+++/++)
Method Description
The TF-specific ADCs were added to A431 cells, with either a 72 h incubation or a 4 h incubation followed by removal of excess ADC and culture for another 68 h. A440cells were lysed in CTG assay reagent after treatment.
In Vitro Model Skin squamous cell carcinoma A431 cells CVCL_0037
References
Ref 1 Anti-tissue factor antibodies, antibody-drug conjugates, and related methods